Table 2 Baseline characteristics of patients in the full analysis set (FAS)

Sex

Male

18 (52.9 %)

17 (53.1 %)

24 (66.7 %)

Female

16 (47.1 %)

15 (46.9 %)

12 (33.3 %)

Age

Mean ± SD (years)

59.9 ± 10.0

56.5 ± 14.7

57.8 ± 13.9

Primary disease

Primary glomerular disease

28 (82.4 %)

27 (84.4 %)

25 (69.4 %)

Nephrosclerosis

6 (17.6 %)

5 (15.6 %)

11 (30.6 %)

1/SCr time slope during the run-in period

Mean ± SD (dL/mg over 4 weeks)

−0.01210 ± 0.00497

−0.01535 ± 0.00808

−0.01198 ± 0.00788

SCr^a

Mean ± SD (mg/dL)

2.377 ± 0.665

2.251 ± 0.618

2.564 ± 0.705

Urinary protein excretion^a

Mean ± SD (mg/day)

2103.7 ± 1523.0

2037.5 ± 1763.4

1753.9 ± 1396.2

Systolic blood pressure^a

Mean ± SD (mmHg)

122.7 ± 16.1

129.0 ± 13.3

129.4 ± 15.6

Diastolic blood pressure^a

Mean ± SD (mmHg)

72.5 ± 11.0

73.4 ± 10.3

75.1 ± 10.6

Concomitant medication

ACEI (+)

13 (38.2 %)

9 (28.1 %)

12 (33.3 %)

ACEI/ARB positive

ARB (+)

25 (73.5 %)

26 (81.3 %)

25 (69.4 %)